1st Quarter - Report

BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION

Firm
Client
Income
—
Expenses
$410,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Transpacific Partnership (TPP) - Supporting passage for greater regulatory harmonization across Asia-Pacific country members and to include transparency and procedural fairness provisions in the agreement. Transatlantic Trade & Investment Partnership (T-TIP) - Supporting passage for greater regulatory harmonization of product approvals and registration

LobbyistCovered position, as disclosed
PAUL E BARRY —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Veterans VET

VHA Directive 2009-053 - Pain care directive - working to increase veteran access to pain specialists and FDA approved alternative treatments in the VHA. Public Law No 113-146 - Veterans Access, Choice, and Accountability Act: Implementation of law to allow veterans to seek healthcare from non-VA facilities if unable to receive care from the VA in a timely manner. VA Vendor Credentialing - Proposals to establish a national credentialing system for VA National Pain Strategy - Encouraging adaption of the NIH's National Pain Strategy H.R. 4063 - Promise Act - Legislation to improve quality of Pain Care provided

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4063 (114th)

Budget/Appropriations BUD

Public Law No 113-6 - CONSOLIDATED AND FURTHER CONTINUING APPROPRIATIONS ACT, 2013 - Specifically, have been working on relief of 5% sequestration of FDA CDRH User Fees Public Law No: 113-67 - Making continuing appropriations for fiscal year 2014, and for other purposes. Specifically provisions providing appropriations for the FDAs CDRH evaluation of medical technology. FY 2016 Agriculture Appropriations Bill (House) - FDA Funding FY 2016 Agriculture Appropriations Bill (Senate) - FDA Funding

LobbyistCovered position, as disclosed
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Transportation TRA

FAA Re authorization - Limitations on aircraft transportation of lithium batteries

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Comprehensive/Corporate Tax Reform W&M Discussion Draft - Includes lower corporate tax rate, research credit transition, and base erosion Senate Finance Tax Reform Discussion Draft - International Tax Reform Provisions - Tax Extender Provisions

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

H.R. 3326 Defend Trade Secrets Act - legislation to establish a Federal Civil cause of action for Trade Secret Misappropriation S. 1890 - Defend Trade Secrets Act - legislation to establish a Federal Civil cause of action for Trade Secret Misappropriation

LobbyistCovered position, as disclosed
PAUL E BARRY —
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3326 (114th), S. 1890 (114th)

Health Issues HCR

Public Law 112-144 - Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) specifically pertaining to user fees used to train FDA staff and streamline approval process Unique Device Identifiers (UDI) - Implementation of UDI rule H.R. 6 - 21st Century Cures Initiative - Legislation to accelerate the pace of biomedical innovation and cures by modernizing federal research and regulatory agencies Innovation for Healthier Americans (Senate, companion) - Legislation to accelerate the pace of biomedical innovation and cures by modernizing federal research and regulatory agencies FDA/CMS Breakthrough Pathway - Legislation to harmonize CMS Reimbursement with FDA Approval to speed products' market introduction S. 524 - H.R. 943 - Comprehensive Addiction & Recovery Act (CARA) - Bill to address the National Opioid epidemic. Specifically, Advocacy for FDA approved alternative treatments for Chronic Pain H.R. 4641 - Pain Best Practices

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4641 (114th), S. 524 (114th), H.R. 943 (114th), H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.